Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 3.1 Amended and Restated Articles of Incorporation of Accentia Biopharmaceuticals
- 3.2 Amended and Restated Bylaws of Accentia Biopharmaceuticals, Inc
- 10.1 Notice of Effectiveness Dated November 17, 2010
- 99.1 Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Unregistered Sales of Equity Securities; Material Modifications to Rights of Security Holders; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Regulation FD Disclosure; Financial Statements and Exhibits
ABPI similar filings
- 21 Jan 11 Departure of Directors or Certain Officers
- 6 Jan 11 Biovest to Present at OneMedForum Conference
- 3 Dec 10 Accentia Biopharmaceuticals Announces Strategic Agreement with Baxter
- 23 Nov 10 Entry into a Material Definitive Agreement
- 2 Nov 10 Accentia Announces Confirmation of Plan of Reorganization
- 25 Oct 10 Biovest Announces $7 Million Financing Required to Exit from
- 24 Sep 10 Regulation FD Disclosure
Filing view
External links